Sort
16,300 grants matching “fatty liver disease”
The Role of Hepatic FMO3 in Ethanol Induced Liver Injury
$54,194Stephanie Marshall · Yale University · F32 · FY2015 · AA
Regulation of the microbiome by epigenetic programming of the immune system
$54,194Amanda Prince · Baylor College Of Medicine · F32 · FY2015 · HD
The Role of the Mediator Complex in the Transcriptional Regulation of Lipogenesis
$54,194Jose Abraham Viscarra · University Of California Berkeley · F32 · FY2015 · DK
Role of Serotonin Signaling in POMC Neurons to Regulate Lipid Homeostasis
$54,194Caleb C Lord · Ut Southwestern Medical Center · F32 · FY2015 · DK
Role of Protein Malonylation in Regulating Mitochondrial Function
$54,194Kelsey Fisher-Wellman · Duke University · F32 · FY2015 · DK
Mechanisms of Brd2 immunoprotection from insulin resistance
$54,139Gerald V Denis · Boston University Medical Campus · R56 · FY2011 · DK
INVESTIGATOR INITIATED STUDY OF THE EFFECTS OF ANDROGEN THERAPY ON CARBOHYDRA
$54,078Fred R Sattler · University Of Southern California · M01 · FY2008 · RR
The Pathogenesis of Steatosis in Hepatitis C Genotype 3 Infection
$54,000Ravi R. Jhaveri · Duke University · K08 · FY2009 · DK
Patient Oriented Research & Mentoring in liver diseases
$54,000Kris Kowdley · Benaroya Research Inst At Virginia Mason · K24 · FY2009 · DK
Aspirin and Novel Lipid Mediators in Nonalcoholic Fatty Liver Disease
$54,000Tracey Simon · Massachusetts General Hospital · K23 · FY2022 · DK
The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
$54,000Laura Elisabeth Dichtel · Massachusetts General Hospital · K23 · FY2020 · DK
Genetics of Type 2 Diabetes
$54,000Steven C Elbein · Wake Forest University Health Sciences · R01 · FY2010 · DK
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$53,999Ryan Eugene Temel · University Of Kentucky · R01 · FY2016 · HL
Role of Muscle Ketone Metabolism in Mediating the Metabolic Benefits of Weight Loss
$53,987Ashley Silberman Williams · Duke University · K01 · FY2022 · DK
AKR1a1 as a novel therapeutic target for Non-Alcoholic Fatty Liver Disease
$53,974Nicholas Venetos · Case Western Reserve University · F30 · FY2024 · DK
Regulation of hepatic lipid metabolism by novel protein BASIC
$53,974Lauren F Uchiyama · University Of California Los Angeles · F30 · FY2024 · DK
Adipocyte-derived exosomes in macrophage regulation
$53,974Joshua Harrison Goodman · Columbia University Health Sciences · F30 · FY2024 · DK
Investigating Metabolically Protective Members of the Microbiota that Modulate Ceramides
$53,974Kendra Alyse Klag · University Of Utah · F30 · FY2024 · DK
The Role of Plasmalogen Mitochondrial and Endothelial Antioxidant Properties in Sepsis
$53,974Reagan McGuffee · Saint Louis University · F30 · FY2024 · HL
Beneficial microbe driven rewiring of metabolic pathways in the gut and liver
$53,974Camilo Anthony G Gacasan · Emory University · F30 · FY2024 · DK
RBP4, Inflammation, and Insulin Resistance
$53,942Julie Elizabeth Norseen · Beth Israel Deaconess Medical Center · F32 · FY2012 · DK
Roles for Rho Proteins During Specific Stages of Breast Cancer Metastasis.
$53,942John Lamar · Massachusetts Institute Of Technology · F32 · FY2012 · CA
Analysis of the Spatiotemporal Regulation of Lipolysis
$53,942Lisa M. Dipilato · University Of Pennsylvania · F32 · FY2012 · DK
The Role of GPR120 and Omega-3 Fatty Acids in Steatosis and Systemic Inflammation
$53,942Sarah J Carlson · Boston Children'S Hospital · F32 · FY2012 · HD
Role of Butyrate in the Gut-Liver Interaction of Ethanol Induced Liver Injury
$53,942Gail Ann Cresci · Cleveland Clinic Lerner Com-Cwru · F32 · FY2013 · AA